Gastric cancer is one of the most common cancers in Korea and the world. Since 2004, this
is the 4th gastric cancer guideline published in Korea which is the revised version of …

Gastric cancer (GC) is one of the most common malignancies worldwide and it is the fourth
leading cause of cancer-related death. GC is a multifactorial disease, where both …

Gastric cancer is the third leading cause of cancer-related deaths worldwide. Over 95% of
gastric cancers are adenocarcinomas, which are typically classified based on anatomic …

Background Accurate clinical staging is crucial to managing gastrointestinal cancer, but
fluorine 18 (18F) fluorodeoxyglucose (FDG) PET/CT has limitations. Targeting fibroblast …

Gastric cancer is the fifth most frequently diagnosed cancer and the third leading cause of
death from cancer in the world. Several advances have been made in the staging …

Gastric cancer is the fifth most common cancer and the third most common cause of cancer
death globally. Risk factors for the condition include Helicobacter pylori infection, age, high …

We sought to evaluate the performance of 68Ga-DOTA-FAPI-04 (68 Ga-FAPI) PET/MR for
the diagnosis of primary tumor and metastatic lesions in patients with gastric carcinomas …

Purpose This study aimed to compare the performance of [68Ga] Ga-DOTA-FAPI-04 and
[18F] FDG PET/CT in the evaluation of primary and metastatic lesions of gastric cancer …

Since its introduction in the early nineties as a promising functional imaging technique in the
management of neoplastic disorders, FDG-PET, and subsequently FDG-PET/CT, has …

Introduction The low sensitivity of [18 F]-fluorodeoxyglucose ([18 F]-FDG) for the diagnosis of
gastric cancer limits its application. In this study, we aimed to investigate the potential …